Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Medtronic splits off MiniMed
This transaction completes Medtronic’s separation of its diabetes unit
McKesson $1.4 billion investment in Option Care Health
We are advising McKesson on the transaction
Immix Biopharma $125 million stock offering
We advised the book-running manager on the offering
InnovAge $92.5 million secondary offering
We advised the underwriters on the offering
Smith+Nephew $700 million notes offering and concurrent tender offer
We advised Smith+Nephew on the offering
Thyme Companies $125 million Series E financing
We advised Morgan Health as lead investor on the financing
Coherus Oncology $50 million at-the-market offering
We advised the sales agent on the offering
Moderna $3 billion convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Jazz Pharmaceuticals $1.25 billion exchangeable senior notes offering
We advised the initial purchasers on the offering
JATT III Acquisition Corp $69 million SPAC IPO
We advised the sole bookrunning manager on the IPO